| |
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations.
Hederman AP, Natarajan H, Heyndrickx L, Arien KK, Wiener JA, Wright PF, Bloch EM, Tobian AAR, Redd AD, Blankson JN, Rottenstreich A, Zarbiv G, Wolf D, Goetghebuer T, Marchant A, Ackerman ME
Nat Commun. 2023 Aug 24;14(1):5171. doi: 10.1038/s41467-023-40960-0. Epub 2023 Aug 24.
PMID: 37620337 Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages.
Chernyshev M, Sakharkar M, Connor RI, Dugan HL, Sheward DJ, Rappazzo CG, Stalmarck A, Forsell MNE, Wright PF, Corcoran M, Murrell B, Walker LM, Karlsson Hedestam GB
Nat Commun. 2023 Apr 19;14(1):2249. doi: 10.1038/s41467-023-37972-1. Epub 2023 Apr 19.
PMID: 37076511 The dangers of castor oil tea in neonates in rural Haiti: A case report.
Jean Baptiste W, Casseus M, Dev A, Joseph P, Wright PF
Front Pediatr. 2023;11:877550. doi: 10.3389/fped.2023.877550. Epub 2023 Mar 6.
PMID: 36950175 Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study.
Erdem R, De Coster I, Withanage K, Mercer LD, Marchant A, Taton M, Cools N, Lion E, Cassels F, Higgins D, Ivinson K, Locke E, Mahmood K, Wright PF, Gast C, White JA, Ackerman ME, Konopka-Anstadt JL, Mainou BA, Van Damme P
Vaccine. 2023 Mar 3;41(10):1657-1667. doi: 10.1016/j.vaccine.2023.01.048. Epub 2023 Feb 4.
PMID: 36746739 Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data.
Hughes SM, Levy CN, Katz R, Lokken EM, Anahtar MN, Hall MB, Bradley F, Castle PE, Cortez V, Doncel GF, Fichorova R, Fidel PL Jr, Fowke KR, Francis SC, Ghosh M, Hwang LY, Jais M, Jespers V, Joag V, Kaul R, Kyongo J, Lahey T, Li H, Makinde J, McKinnon LR, Moscicki AB, Novak RM, Patel MV, Sriprasert I, Thurman AR, Yegorov S, Mugo NR, Roxby AC, Micks E, Hladik F, Consortium for Assessing Immunity Across the Menstrual Cycle
BMC Med. 2022 Oct 5;20(1):353. doi: 10.1186/s12916-022-02532-9. Epub 2022 Oct 5.
PMID: 36195867 SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations.
Hederman AP, Natarajan H, Wiener JA, Wright PF, Bloch EM, Tobian AAR, Redd AD, Blankson JN, Rottenstreich A, Zarbiv G, Wolf D, Goetghebuer T, Marchant A, Ackerman ME
medRxiv. 2022 Sep 18; pii: 2022.09.15.22280000. doi: 10.1101/2022.09.15.22280000. Epub 2022 Sep 18.
PMID: 36172122 Bronchiolitis hospitalizations in rural New England: clues to disease prevention.
Wright PF, Hoen AG, Jarvis JD, Zens MS, Dade EF, Karagas MR, Taube J, Brickley EB
Ther Adv Infect Dis. 2022 Jan-Dec;9:20499361221099447. doi: 10.1177/20499361221099447. Epub 2022 May 27.
PMID: 35651526 Enterovirus D68 in the Anterior Horn Cells of a Child with Acute Flaccid Myelitis.
Vogt MR, Wright PF, Hickey WF, De Buysscher T, Boyd KL, Crowe JE Jr
N Engl J Med. 2022 May 26;386(21):2059-2060. doi: 10.1056/NEJMc2118155.
PMID: 35613028 Corrigendum to "Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial" [Vaccine 40(19) (2022) 2705-2713].
Crothers JW, Ross Colgate E, Cowan KJ, Dickson DM, Walsh M, Carmolli M, Wright PF, Norton EB, Kirkpatrick BD
Vaccine. 2022 May 31;40(25):3481. doi: 10.1016/j.vaccine.2022.05.001. Epub 2022 May 6.
PMID: 35534312 Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial.
Crothers JW, Ross Colgate E, Cowan KJ, Dickson DM, Walsh M, Carmolli M, Wright PF, Norton EB, Kirkpatrick BD
Vaccine. 2022 Apr 26;40(19):2705-2713. doi: 10.1016/j.vaccine.2022.03.056. Epub 2022 Mar 30.
PMID: 35367069 View more publications on PubMed |